Filter
736
Filtered Results: 736
Text search:
N.
Kumar
Featured
Recommendations
68
New Publications
157
Language
Document type
No document type
406
Studies & Reports
124
Guidelines
123
Manuals
43
Fact sheets
17
Strategic & Response Plan
12
Training Material
7
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
139
Nepal
34
Global
26
Bangladesh
15
Brazil
10
Asia
10
Kenya
9
Western and Central Europe
8
Russia
8
Germany
6
South Africa
6
Malawi
5
Mozambique
5
Myanmar / Burma
5
South–East Asia Region
5
Guinea
4
Cameroon
4
Colombia
4
Lesotho
4
Middle East and North Africa
4
Eastern Europe
4
Burkina Faso
3
Sierra Leone
3
Liberia
3
Ethiopia
3
Ghana
3
Uganda
3
Zambia
3
Tanzania
3
Indonesia
3
Benin
3
Ukraine
3
Ecuador
3
Sri Lanka
3
East and Southern Africa
3
Latin America and the Carribbean
3
Eastern Europe and Central Asia
3
Nigeria
2
Guinea-Bissau
2
Zimbabwe
2
Philippines
2
South Sudan
2
Thailand
2
Rwanda
2
Argentina
2
Angola
2
West and Central Africa
2
Africa
2
Bhutan
2
Tajikistan
2
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Niger
1
Pakistan
1
Jordan
1
Afghanistan
1
Syria
1
Chad
1
China
1
Sudan
1
Eswatini/ Swaziland
1
Burundi
1
Yemen
1
Western Pacific Region
1
Venezuela
1
North Korea
1
Timor Leste/ East Timor
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
262
Clinical Guidelines
97
Public Health
55
Women & Child Health
37
Key Resources
17
Capacity Building
5
Pharmacy & Technologies
5
Toolboxes
TB
91
COVID-19
74
HIV
61
Mental Health
44
Disability
33
Caregiver
33
NTDs
31
Planetary Health
28
AMR
15
Pharmacy
12
NCDs
12
Rapid Response
9
Refugee
9
Global Health Education
8
Natural Hazards
7
Health Financing Toolbox
5
Ebola
4
Polio
4
Conflict
2
Cholera
1
Specific Hazards
1
Social Ethics
1
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
Scientific Brief, 30 June 2020
Options for the decontamination and reuse of respirators in the context of the COVID-19 pandemic
recommended
Guiding principles for reuse are:
Respirators which have been visibly contaminated (e.g. during procedure at intubated patients, such as suction cleaning of airways, taking probes, extubation attempts, etc.) or are damaged or not fitting, should be discarded and cannot be taken for re-use or de...
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom ...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
The COVID-19 pandemic poses an additional and critical challenge in a fragile humanitarian context, where the population is already highly vulnerable and lives in often overcrowded settlements where distancing is impossible, and with limited access to basic health services and hygiene. Further sprea...
Se calcula que en 2015 había en el mundo 17,8 millones de mujeres de 18 años o mayores infectadas por el VIH, cifra que equivale al 51% de los adultos que viven con VIH. Las adolescentes y las jóvenes se ven especialmente afectadas; en 2015 constituían el 60% de los individuos entre 15 a 24 año...
Shielding is a term used to describe the protection of individuals at high risk of severe COVID-19 illness by separating them from the general population.
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
Guidance for addressing a global infodemic and fostering demand for immunization
December 2020
Misinformation threatens the success of vaccination programs across the world. This guide aims to help organizations to address the global infodemic through the development of strategic and well-coordina...
Orientations pour faire face à une infodémie mondiale et favoriser la demande de vaccination
Décembre 2020
La désinformation menace le succès des programmes de vaccination dans le monde entier. Ce guide vise à aider les organisations à faire face à l'infodémie mondiale par l'élaboration ...
BMJ Global Health2020;5:e002014. doi:10.1136/bmjgh-2019-002014
